reference/5766362

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5766362

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	29
issn	1473-1150 1470-269X
issueIdentifier	1
pageRange	21-29
publicationName	The Pharmacogenomics Journal
startingPage	21
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d5270a6e24d0dd028d1d2afff61362c9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5a60371e17b72be0c36997141bf192a1
bibliographicCitation	Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC, Curry SJ, McAfee T. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. The Pharmacogenomics Journal. 2004 Oct 19;5(1):21–9. doi: 10.1038/sj.tpj.6500281.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a9dd98191c4a20600a4dbb9c489222 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f054c3aa2ffb041f9f4c05245b9aba6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f129b1b6b9aa730be9b63d7167507a10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1411b98d93fabaab69809af8ff4fd6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81fe470f4775c42f1315b2338adbf8ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9081d14e33903abb9921036db66d7fb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbf94e51c923125f6fb6c74847d89a2f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d5a702c9d109820a9bdf1a9b33de3b78
date	2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15492764 https://doi.org/10.1038/sj.tpj.6500281
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22416 https://portal.issn.org/resource/ISSN/1470-269X https://portal.issn.org/resource/ISSN/1473-1150
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR
discusses	http://id.nlm.nih.gov/mesh/M0025361 http://id.nlm.nih.gov/mesh/M0026473
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10420 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a20a852de6e0b3ecac342b0499ddb5b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129544235 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404

Total number of triples: 42.